Plasma-seq: a novel strategy for metastatic prostate cancer analysis

Personalized genomics will only be useful for monitoring the prognosis of patients with cancer when it becomes much more cost-effective and quicker to apply. A recent study brings this closer to reality with the development of plasma-seq, a rapid, low-cost method that sequences the circulating DNA p...

Descripción completa

Detalles Bibliográficos
Autores principales: Farris, Caitlin, Trimarchi, Jeffrey M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Highlight
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706850/
https://www.ncbi.nlm.nih.gov/pubmed/23673197
http://dx.doi.org/10.1186/gm439
Descripción
Sumario:Personalized genomics will only be useful for monitoring the prognosis of patients with cancer when it becomes much more cost-effective and quicker to apply. A recent study brings this closer to reality with the development of plasma-seq, a rapid, low-cost method that sequences the circulating DNA present in the peripheral blood of patients with cancer. The power of this technique is demonstrated with the examination of tumor genomes from patients with prostate cancer. See related research article: http://genomemedicine.com/content/5/4/30

Ejemplares similares